Hussman Strategic Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.08M	Sell	84,000 -21,000	-20%	-$500K	0.45%	97
2025 Q4	$2.45M	Sell	105,000 -42,000	-29%	-$936K	0.59%	57
2025 Q3	$2.9M	Hold	147,000	–	–	0.63%	39
2025 Q2	$3.19M	Buy	147,000 +63,000	+75%	+$1.49M	0.73%	40
2025 Q1	$2.04M	Sell	84,000 -21,000	-20%	-$473K	0.49%	80
2024 Q4	$2.19M	Hold	105,000	–	–	0.65%	51
2024 Q3	$2.09M	Hold	105,000	–	–	0.51%	88
2024 Q2	$1.63M	Hold	105,000	–	–	0.45%	99
2024 Q1	$1.67M	Sell	105,000 -52,500	-33%	-$791K	0.39%	101
2023 Q4	$2.65M	Hold	157,500	–	–	0.6%	59
2023 Q3	$1.84M	Buy	157,500 +64,500	+69%	+$863K	0.35%	119
2023 Q2	$1.25M	Hold	93,000	–	–	0.23%	188
2023 Q1	$1.54M	Buy	93,000 +31,000	+50%	+$511K	0.24%	172
2022 Q4	$1.15M	Hold	62,000	–	–	0.19%	187
2022 Q3	$795K	Sell	62,000 -68,000	-52%	-$806K	0.14%	229
2022 Q2	$911K	Buy	130,000 +62,000	+91%	+$455K	0.16%	210
2022 Q1	$564K	Hold	68,000	–	–	0.11%	248
2021 Q4	$460K	Sell	68,000 -56,000	-45%	-$368K	0.1%	256
2021 Q3	$657K	Hold	124,000	–	–	0.14%	210
2021 Q2	$713K	Buy	+124,000	New	+$640K	0.15%	229